Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Phys Med Biol. 2008 Jul 31;53(16):4455–4470. doi: 10.1088/0031-9155/53/16/016

Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions

U Titt 1, N Sahoo 1, X Ding 1, Y Zheng 1, W D Newhauser 1, X R Zhu 1, J C Polf 1, M T Gillin 1, R Mohan 1
PMCID: PMC4131262  NIHMSID: NIHMS612614  PMID: 18670050

Abstract

In recent years, the Monte Carlo method has been used in a large number of research studies in radiation therapy. For applications such as treatment planning, it is essential to validate the dosimetric accuracy of the Monte Carlo simulations in heterogeneous media. The AAPM Report no 105 addresses issues concerning clinical implementation of Monte Carlo based treatment planning for photon and electron beams, however for proton-therapy planning, such guidance is not yet available. Here we present the results of our validation of the Monte Carlo model of the double scattering system used at our Proton Therapy Center in Houston. In this study, we compared Monte Carlo simulated depth doses and lateral profiles to measured data for a magnitude of beam parameters. We varied simulated proton energies and widths of the spread-out Bragg peaks, and compared them to measurements obtained during the commissioning phase of the Proton Therapy Center in Houston. Of 191 simulated data sets, 189 agreed with measured data sets to within 3% of the maximum dose difference and within 3 mm of the maximum range or penumbra size difference. The two simulated data sets that did not agree with the measured data sets were in the distal falloff of the measured dose distribution, where large dose gradients potentially produce large differences on the basis of minute changes in the beam steering. Hence, the Monte Carlo models of medium- and large-size double scattering proton-therapy nozzles were valid for proton beams in the 100 MeV–250 MeV interval.

Introduction

In 2006, The University of Texas, M D Anderson Cancer Center started treating patients at the newly built Proton Therapy Center in Houston (PTCH) (Smith et al 2003, Newhauser et al 2007b). The facility utilizes three identical passive scattering nozzles. Two are mounted on rotational gantries, and the other one is mounted in a fixed horizontal orientation. The dose distributions from these nozzles are of particular interest, because the nozzles are currently being used in clinical service. In the future, a scanned-beam nozzle and a low-energy ocular treatment nozzle will be commissioned. Pre-clinical preparation of the three passive scattering nozzles included the generation of measured and simulated proton field properties, including the lateral proton fluence, and absorbed-dose profiles and depth-dose profiles.

A validated Monte Carlo system for the simulation of radiation transport is a useful tool for pre-clinical and clinical research studies (Paganetti et al 2004). For example, Monte Carlo simulations have been used to provide dosimetric data for the configuration and testing of a commercial treatment planning system (Newhauser et al 2007b), assessment of dosimetric perturbations from implanted localization markers, stray radiation exposures to patients (Fontenot et al 2008), virtual commissioning of an ocular treatment planning system (Koch and Newhauser 2005), dose per monitor-unit predictions (Koch et al 2008), neutron shielding in a proton-therapy facility (Titt and Newhauser 2005), collimator scatter (Titt et al 2008) and in various other applications (Newhauser et al 2002a, 2002b, 2005a, 2005b, 2007a, 2007b, 2007c, Zhang et al 2007, Fontenot et al 2007, de Crevoisier et al 2007, Bues et al 2005, Zheng et al 2007a, Mourtada et al 2005, Fontenot et al 2005, Koch and Newhauser 2005, Polf et al 2005, 2007, Titt and Newhauser 2005, Polf and Newhauser 2005, Melancon et al 2007).

Despite its use in these applications, the dosimetric accuracy of M D Anderson’s Monte Carlo proton-therapy simulation system has not been comprehensively validated, because the prerequisite beam data measurements are yet unavailable. In this work, we describe our efforts to validate the Monte Carlo simulation model of the double scattering nozzles used at the PTCH. We compared simulated beam data with experimental data measured during the clinical commissioning of the PTCH. Specifically, we compared simulations and measurements of lateral-dose profiles and per cent depth-dose profiles of proton beams with a range in water of 3.5 cm–28.5 cm. Dose distributions were obtained in a simple homogeneous water phantom and in a simple heterogeneous phantom that approximated a thorax. Standard figures of merit were used to quantitatively assess the levels of agreement between these data sets, including dose-difference and distance to agreement.

Materials and methods

Experimental set-up

Commissioning measurements in a homogeneous water phantom

The proton accelerator at the PTCH, a synchrotron, provides proton energies between 100 and 250 MeV. The beams are extracted from the accelerator and directed into the treatment rooms using magnetic fields that steer the beam through vacuum beam pipes. In the treatment rooms, the beam enters a nozzle housing beam-modifying devices, which change the beam parameters according to the requirements defined by the treatment plan. The passive scattering nozzles at the PTCH are composed of double scattering systems that include (1) a first scatterer that spreads the narrow proton beam upstream of a range modulator wheel (RMW), a rotating wheel with varying thicknesses that produces a spread-out Bragg peak (SOBP); and (2) a second scatterer that provides a uniform dose across the field size (Koehler et al 1977) at a specified depth (isocenter). At the PTCH, three different sets of beam-modifying devices are used to provide different field sizes: (1) the ‘small snout’, used for field sizes up to 10 cm × 10 cm; (2) the ‘medium snout’, used for field sizes up to 18 cm × 18 cm; and (3) the ‘large snout’, used for field sizes up to 25 cm × 25 cm. Each snout uses different first scatterers and second scatterers and a set of three RMWs, which provide the required uniformity of dose at the isocenter for any given range of the proton beam in water. Because the energy of the proton beam entering the double scattering nozzle is divided into eight energy intervals, a set of range shifters, i.e., plastic slabs of varying thickness, is used to produce the required proton range with a resolution of 1 mm water-equivalent thickness. Detailed descriptions of the nozzle set-up have previously been published (Newhauser et al 2007b, Zheng et al 2007a).

Prior to clinical use, a set of commissioning measurements was performed for each RMW covering (among other parameters) the per cent depth doses (PDDs) and lateral-dose profiles in a water phantom for various proton ranges and SOBPs. The PTW MP3 water-tank scanning system and MEPHISTO mc2 software (both from PTW, Freiburg, Germany) were used to measure the PDDs with an Advanced Markus parallel plate chamber (PTW model 340045, SN 293 or SN 0304) and cross-beam profiles with a PTW pinpoint chamber (PTW model 31006, SN 376 and SN 0079). A reference chamber was always used during data acquisition to control for dose-rate fluctuations of the beam. The water phantom was located with its upstream surface at a distance of 270 cm from the source (SSD = 270 cm), which is equal to the isocenter location. Some of the profiles were measured using EDR-2 films, which were scanned using a VIDAR Pro 16 scanner, and were analyzed using OmniPro-Accept 6.4 A software (Scanditronix Wellhöfer GmbH, Schwarzenbruck, Germany).

For all RMWs (except for the lowest proton energies), PDDs at full range and at minimum range (all range shifter plates in the beam) were recorded, and several SOBP widths were measured for each RMW. For each PDD, several lateral dose distributions were measured, typically at the center of the SOBP, 2 mm upstream of the distal edge (90% dose) and in the proximal region of the peak.

The snout holds a final collimator that conforms the beam to the lateral projection of the target. Square brass collimators with apertures of 23.4 cm × 23.4 cm and 16.6 cm × 16.6 cm (physical size, not projected to isocenter) were used in the large snout and in the medium snout, respectively. The reproducibility of the measured ranges (to the distal 90% depth) and SOBP widths (separation of distal 90% and proximal 95%) were within 1 mm. The chamber positioning uncertainties were estimated at less than 1 mm. The uncertainties in the measurement of flatness and symmetry of the profiles were estimated at less than 1%.

Proton beam scattering measurements in a heterogeneous phantom

Bone-equivalent plastic rods (density ρ = 1.82 g cm−3, diameter = 2 cm, height = 20 cm) were located 2 mm downstream of the phantom wall, corresponding to a water-equivalent depth of 25 mm with a center-to-center distance of 3 cm. A 5 cm thick lung-equivalent plastic slab (density ρ = 0.3 g cm−3) was then placed downstream of the rods. The elemental composition (vendor provided) of the bone-equivalent plastic was 2.41% H, 31.41% C, 1.84% N, 36.5% O, 0.04% Cl and 26.81% Ca. The lung-equivalent plastic was composed of 8.4% H, 59.38% C, 1.96% N, 18.14% O, 11.19% Mg, 0.78% Si and 0.1% Cl. PDDs and lateral-dose profiles were measured behind the slab for initial proton-beam energies of 225 MeV, 200 MeV and 180 MeV, which are typical proton energies used in thoracic treatments. The maximum ranges of these beams in water are 23.6 cm, 19.0 cm and 16.1 cm, respectively. The 180 MeV beam was measured once at full range and once with the minimum range (13.1 cm in water), i.e., with all range shifter plates in the beam line.

The depths of the lateral profiles were 20.8 cm and 16.2 cm for the 225 MeV and 200 MeV beams, respectively, and both 13.3 cm and 10.8 cm for the 180 MeV beam. (SSD = 270 cm) In all beams the SOBP width was 10 cm. All beams were delivered through an 8.3 cm × 8.3 cm aperture in the brass collimator, which was positioned 8 cm from the phantom surface for the 225 MeV and 200 MeV beams. This distance was 48 cm for the 180 MeV measurements. The variation in snout-to-water phantom distance was introduced to validate the Monte Carlo model with respect to changes in the lateral penumbra that occur due to the geometric changes in the set-up and due to potential changes in dose deposition from collimator scatter (Titt et al 2008).

Monte Carlo model

Homogeneous water phantom simulations

The Monte Carlo simulations in this study were carried out using the MCNPX code (version 2.5.0; LANL, Los Alamos, NM), a general-purpose radiation-transport-simulation code capable of simulating proton beams (Waters et al 2005). This code uses tabulated cross-sectional data up to a maximum energy, which is particle and material dependent, and beyond this maximum energy, the program uses model-based transport parameters. This code requires an input file that defines the geometry, physics parameters, and tallies of the simulated problem. The geometric set-up used in this study was developed by Newhauser et al (2007b) and Zheng et al (2007b).

The particle source and transport parameters were set as follows. The proton source was located at the upstream surface of the beam-exit window of the beam-delivery system. Its spatial distribution was described by two Gaussian distributions with a full-width half-maximum (FWHM) value of 0.54 cm in the x-direction and 1.22 cm in the y-direction. Additionally a so-called cookie-cutter cell was defined to limit the start position of the source particles to a radius of 3 cm around the beam axis. The energy of the protons was also modeled with Gaussian distributions, with a FWHM ranging from 0.23% for 250 MeV beams to 0.3% for 100 MeV beams of the nominal proton energy at the nozzle entrance. The energy spread was selected according to the specifications of the manufacturer of the synchrotron used at the PTCH. The initial direction of the source particles was parallel to the beam axis. The default kinetic energy cutoff value used was 1 MeV, at which the proton transport was terminated, and all remaining energy was deposited locally. The transport parameters were set to employ the ‘mix and match’ capability of the program, i.e., a smooth transition was realized when the transport was changing from model-based parameters to tabulated parameters. Straggling was performed with the Vavilov model (Vavilov 1957), and light-ion recoil was suppressed.

The geometries were detailed models of the medium- and large-size nozzles, comprising the beam-modifying devices, which are present in the physical nozzles. The parts were modeled according to material specifications and structural designs provided by the vendor (Hitachi Ltd, Japan). A schematic of the design is shown in figure 1. Detailed descriptions have been provided by Newhauser et al (2007b) and Zheng et al (2007b).

Figure 1.

Figure 1

Schematic drawing of the Monte Carlo model of the nozzle. The proton source (S) is located on the left. Downstream of a reference monitor (RM) chamber, the first scatterer (FS) is located upstream of the range modulator wheel (RMW). A second scatterer (SS) follows, and downstream of the SS, range shifters (RS) are positioned so that they can be inserted into the beam if the range has to be adjusted. Following these scatterers, two dose monitors (DM) are located upstream of a brass collimator (A). Finally, the beam enters the water phantom (WP) on the right.

A mesh tally was located in the water phantom, which provided energy deposition per unit volume per particle history in units of MeV cm−3 n−1. In water (density ρ = 1 g cm−3), this value corresponds to the dose deposited per particle history in units of MeV g−1 n−1. The spatial resolution of the tally was 1 mm × 8 cm × 1 mm for simulations of the large snout and 1 mm × 4 cm × 1 mm for simulations of the medium snout. The large size of the tally in one direction was implemented to decrease statistical uncertainty in the results, and the orientation was set perpendicular to the beam axis and to the plane of interest (i.e., in the case of a lateral profile in the x-direction, the large side of the tally would be in the y-direction and vice versa). The only variance reduction technique applied in the simulations was weighted-particle splitting of particles entering the water phantom.

The modulation widths of the SOBPs are determined by the gate-off angles of the rotating RMW at which the beam would be turned on and off, so that the beam penetrates the correct thickness of material on the RMW. To generate an SOBP from the simulated data, single Bragg peaks were simulated separately and subsequently combined with post-processing software. The RMW rotation angle was quantized in 3° increments. Each peak was simulated with 107 source particles to achieve statistical uncertainties of less than 1% in the region of interest.

Proton beam scattering simulations in the heterogeneous phantom

The model of the inhomogeneity set-up comprised the same snout set-up and water phantom from the commissioning simulations with the addition of bone-equivalent plastic rods (density ρ = 1.82 g cm−3) that were inserted in the water phantom at the water-equivalent depths of 25 mm, corresponding to the water-equivalent thickness of the position of the rods in the measurements, followed by a 5 cm lung-equivalent slab with a density of 0.3 g cm−3. The transport physics, the tally type, and the dimensions were similar to those of the commissioning simulations. The compositions of the bone-equivalent and lung-equivalent materials are given in table 1.

Table 1.

Atomic composition of the lung-equivalent and bone-equivalent materials used in the Monte Carlo simulations.

Lung Bone


Element Atomic fraction Element Atomic fraction
H 0.64 H 0.47
C 5.45 × 10−2 C 0.12
N 1.38 × 10−2 N 3.04 × 10−2
O 0.29 O 0.28
Na 5.43 × 10−4 Mg 9.18 × 10−4
P 4.03 × 10−4 P 3.44 × 10−2
S 5.843 × 10−4 S 9.97 × 10−4
Cl 5.28 × 10−4 Ca 5.31 × 10−2
K 3.19 × 10−4 Zn 1.55 × 10−5

Comparing simulated and measured dose profiles

Homogeneous water phantom data

The goal of this study was to compare measured dose profiles to Monte Carlo simulated dose profiles for all RMWs. PDDs were normalized to the dose at the center of the SOBP, and lateral profiles were normalized to the average value in the high-dose region, corresponding to 80% of the field size. Three distinct lateral penumbra widths were investigated: the spatial difference between the 90% and 10% dose locations, the 90% and 50% dose locations and the 80% and 20% dose locations. The proton ranges were determined at the 90% dose location at the distal edge of the beam. The SOBP width was determined between the distal 90% and the proximal 95% of the peak region (see figure 2).

Figure 2.

Figure 2

Typical comparison of PDDs. The high-energy beam (250 MeV) is shown with two different SOBP widths (4 cm and 10 cm), and a low-energy beam (120 MeV) is shown with a 1 cm SOBP width. The SOBP (mod) width is defined from the distal 90% to the 95% proximal dose location. There are differences in the proximal region of the peaks, but these are still within tolerance limits.

The validation criteria were as follows: maximum difference in dose ≤3% (in a high-dose region), maximum difference in range or penumbra width ≤3 mm, and maximum difference in SOBP width ≤10 mm. The rather large tolerance for the SOBP width is based on the fact that the proximal 95% dose location is typically positioned in a low-dose-gradient region, where a small change in the dose leads to large changes in the SOBP width. A total of 63 simulated PDDs and 126 simulated lateral-dose profiles were compared with the corresponding measured parameters.

Proton beam scattering data in a heterogeneous phantom

All lateral profiles were normalized to the central axis values. The PDDs were normalized to the values at the center of the SOBPs. The data were then compared in terms of difference in dose, range and penumbra size with acceptance criteria similar to those in the commissioning data.

Results

Homogeneous water phantom data

Figure 2 compares the PDDs obtained from Monte Carlo simulated and measured doses. The PDDs of a beam with maximum range of 28.5 cm (250 MeV at nozzle entrance) in the medium snout is shown for two different SOBP widths (10 cm and 4 cm) measured from the distal 90% to the proximal 95% dose locations. Also shown is the PDD of a beam with an energy of 120 MeV at the nozzle entrance for a SOBP width of 1 cm.

Figure 3 shows a comparison of simulated and measured lateral profiles. The penumbra widths (dotted lines) were measured from the 90% to the 50% dose locations, from the 90% to the 10% dose locations and from the 80% to the 20% dose locations. The field size was determined from the distance between the 50% dose locations. The figure also shows the statistical uncertainties (1 σ confidence interval) associated with the simulated data.

Figure 3.

Figure 3

Example of comparison of lateral dose profiles (left-side scale). These profiles were obtained at a depth of 28.3 cm. The beam had full range (28.5 cm in water, 250 MeV at nozzle entrance) and had a SOBP width of 16 cm. The dotted lines show where the penumbras were measured and the field size was determined from the distance between the 50% dose points. At the right edge of the field, a dose difference (ΔD) of 0.8% is shown. Additionally, the relative statistical uncertainty, σ, of the simulation data is shown in this graph (right-side scale).

The results of the comparison of simulated and measured PDDs using the large snout are given in table 2 for different proton energies (Ep) at the nozzle entrance and the various ranges. The parameters used for comparison are range at the distal 90% dose location (r90); SOBP width (m); and maximum absolute dose difference (ΔDmax), which is given as a percentage of the normalization value at the center of the SOBP. The differences between measured and simulated values for 90% dose location and SOBP width are tabulated as Δr90 and Δm, respectively. In some cases, measured data were unavailable, so the differences were determined between the simulated data and the nominal values of r90 or m, respectively.

Table 2.

Comparison of simulated PDDs to measured PDDs in the large snout. Ep is the proton energy at nozzle entrance, r90 is the nominal range at the distal 90% dose location, and m is the nominal SOBP width of the SOBP.

Ep
(MeV)
r90
(mm)
m
(mm)
Δr90
(mm)
Δm
(mm)
ΔDmax
(%)
250 250 40 0.04 0.09 2.2
250 250 100 0.40 0.75 1.6
250 250 160 0.42 5.44 2.0
250 207 100 0.90* 7.70*
225 206 40 1.00 1.10 3.0
225 206 100 0.50 1.50 2.0
225 206 140 0.80 3.00 1.7
225 166 100 1.50* 7.80*
200 165 160 2.17 0.01 1.5
200 165 100 2.15 2.46 1.9
200 165 140 2.27 1.97 1.8
200 138 60 1.60* 2.24*
180 137 40 2.05 1.89 2.3
180 137 60 2.12 0.59 2.0
180 137 100 2.22 1.35 2.5
180 111 60 1.13* 6.67*
160 110 20 2.05 0.17 3.0
160 110 40 2.03 2.76 2.8
160 110 60 2.02 3.47 3.0
160 110 80 2.07 2.13 2.2
160 110 100 2.11 0.23 1.0
160 85 60 1.06 3.47 3.0
140 84 40 0.61 0.78 1.9
140 74 60 0.69 1.30 2.9
120 63 40 1.07 1.85 1.9
120 63 20 1.24 0.12 2.6
100 43 30 1.17 0.04 2.3
100 35 20 1.28 1.02 2.5

Δr90 is the absolute difference between the simulated and the measured ranges at the distal 90% dose location, Δm is the absolute difference in SOBP width (Δr90 and Δm values with an ‘*’ were compared to the nominal values), and ΔDmax is the maximum absolute dose difference relative to the dose at the center of the SOBP.

The results of the comparison of simulated and measured lateral profiles for the large snout are shown in table 3 for different proton energies, Ep; SOBP widths, m; and depths (z) of the profile relative to the upstream surface of the water phantom, which was located at the isocenter. The absolute differences in the penumbra widths are denoted as ΔP90–10 for the values of the 90%–10% penumbras, ΔP90–50 for the values of the 90%–50% penumbras and ΔP80–20 for the absolute differences in the 80%–20% penumbras. The absolute difference in field size is denoted by ΔFS. The maximum dose difference, ΔDmax, in the high-dose region of the profile is given as a percentage of the dose, normalized to the center region of the profile. Similar data for the medium snout are available directly from the authors.

Table 3.

Comparison of simulated and measured lateral profiles for the large snout. Ep is the proton energy in MeV at nozzle entrance, m is the SOBP width of the SOBP in millimeters, and z is the depth of the profile relative to the upstream surface of the water phantom (isocenter) in millimeters. The absolute differences in the penumbra widths, denoted as ΔP90–10 for the values of the 90%–10% penumbras, ΔP90–50 for the values of the 90%–50% and ΔP80–20 for the absolute differences in the 80%–20% penumbras, are given in millimeters. The differences in field size, ΔFS, measured from the 50% to the 50% dose location, are also given in millimeters. The maximum dose difference, ΔDmax, in the high-dose region of the profile is given in percent of the dose normalized to the center of the profile.

Ep
(MeV)
m
(mm)
z
(mm)
ΔP90–10
(mm)
ΔP90–50
(mm)
ΔP80–20
(mm)
ΔFS
(mm)
ΔDmax
(%)
250 40 248 1.14 0.53 0.96 0.52 0.9
250 40 228 1.41 0.63 1 0.58 0.8
250 40 208 1.37 0.69 0.79 0.51 0.9
250 100 248 1.34 0.61 1.04 0.3 1.0
250 100 199 1.32 0.68 0.89 0.53 0.9
250 100 149 0.68 0.17 0.35 0.52 0.9
250 160 248 1.17 0.63 1.02 0.54 1.0
250 160 163 0.93 0.55 0.38 0.5 1.0
250 160 83 0.33 0.28 0.37 0.13 0.9
250 100 206 1.64 1.07 0.93 0.24 1.5
250 100 157 0.92 0.45 0.52 0.36 1.0
250 100 107 0.15 0.01 0 0.47 0.8
225 40 166 1.33 0.54 0.66 0.57 1.0
225 40 186 0.97 0.64 0.85 0.58 0.9
225 40 205 1.77 0.89 0.91 0.85 1.5
225 100 108 0.39 0.03 0.03 0.49 1.0
225 100 157 1.21 0.52 0.63 0.69 1.0
225 100 205 1.89 0.99 0.92 0.73 0.8
225 140 65 0.32 0.23 0.35 0.33 0.9
225 140 135 0.85 0.3 0.44 0.59 0.9
225 140 205 2.01 1.13 0.97 0.79 1.0
225 100 65 0.30 0.27 0.27 0.24 0.9
225 100 116 0.66 0.10 0.25 0.49 1.0
225 100 165 1.29 0.56 0.61 0.61 1.0
200 40 124 0.45 0.28 0.53 0.59 1.9
200 40 144 1.78 1.02 1.11 1.55 1.5
200 40 164 1.55 1.14 0.69 0.52 1.8
200 100 115 1.14 0.50 0.61 0.57 1.3
200 100 164 1.89 1.15 0.78 0.41 1.8
200 140 60 0.59 0.02 0.17 0.57 1.1
200 140 94 0.46 0.32 0.18 0.52 0.7
200 60 78 0.15 0.16 0.07 0.22 2.2
200 60 108 0.85 0.48 0.40 0.17 0.9
200 60 137 1.21 0.77 0.68 0.04 3.5
180 40 98 0.22 0.05 0.09 0.56 2.5
180 40 117 0.88 0.33 0.44 0.65 2.0
180 40 135 1.36 0.73 0.72 0.69 3.0
180 60 78 0.30 0.11 0.08 0.28 1.5
180 60 107 0.79 0.32 0.40 0.66 2.4
180 60 135 0.77 0.47 0.56 0.18 2.6
180 100 60 0.39 0.19 0.24 0.36 1.3
180 100 85 0.32 0.13 0.12 0.56 1.0
180 100 135 1.43 0.82 0.83 0.73 3.0
180 60 60 0.10 0.18 0.17 0.44 1.0
180 60 80 0.02 0.06 0.02 0.29 0.9
180 60 110 0.96 0.54 0.60 0.76 4.0
160 40 70 0.04 0.20 0.07 0.53 2.3
160 40 90 0.03 0.08 0.01 0.17 2.6
160 40 108 0.14 0.20 0.01 0.08 3.0
160 80 68 0.39 0.26 0.32 0.25 2.1
160 80 108 0.04 0.19 0.16 0.04 3.0
160 60 60 0.34 0.14 0.19 0.36 2.4
160 60 80 0.06 0.00 0.03 0.49 2.7
140 40 64 0.17 0.13 0.16 0.31 2.1
120 40 43 0.21 0.12 0.03 0.43 2.0
100 30 12 0.49 0.34 0.32 0.05 3.0
100 30 28 0.11 0.15 0.01 0.54 1.5

Comparison of the PDD data showed that the median difference between measured and simulated PDD was about 1 mm, and the maximum difference was 2.3 mm. All simulated values were considered acceptable because they agreed with measurement values to within the validation criteria of 3 mm. Figure 4(a) shows the frequency distribution, f, of the absolute range differences. There was no apparent correlation between the range differences and any of the beam parameters. The frequency distribution of the SOBP widths is shown in figure 4(b), which shows a distribution with a maximum of about 7 mm, where 3 of 63 values are larger than 5 mm. The frequency distribution of the maximum dose difference found in PDDs is shown in figure 4(c), which shows a mean value of about 2% of the dose at the center of the SOBP. Eight of 63 simulated PDDs showed a dose difference of 3% compared to the measured curves. Higher dose differences were found at small proton energies, especially at small SOBP widths. However all dose differences were considered acceptable. The absolute values of the maximum dose differences in the lateral profiles are shown in figure 4(d). The distribution also shows extreme outliers, one at 3.6% and another at 4%. These values would be unacceptable. A closer look at the data revealed that both values were derived when simulation data were compared to asymmetric measured curves obtained in the distal falloff of the fields. One possible explanation for the asymmetry is that small changes in beam steering can introduce large asymmetries in the measurements in the high-dose-gradient falloff region. Another possible explanation is that a positioning error of the experimental set-up biased the effective point of the measurement. If the normal vector of the phantom’s surface has a slight angle with respect to the beam axis, an asymmetry would result. Whatever may be the reason for the measured asymmetry, the simulation of the profiles cannot account for ‘real world’ imperfections, and hence are not considered a failure.

Figure 4.

Figure 4

(a) Frequency distribution, f, of the absolute differences of ranges between measured and simulated SOBPs. The mean value is 1.03 mm. (b) Frequency distribution, f, of the absolute differences in SOBP width, m, between measured and simulated PDDs. (c) Frequency distribution of the maximum absolute differences in dose between measured and simulated PDDs. (d) Frequency distribution. f, of the absolute differences in dose between measured and simulated lateral profiles.

Figure 5(a) shows the frequency distribution of the absolute differences in the 90%–10% penumbra of the lateral profiles. The mean value is 0.8 mm, and the maximum difference was 2.3 mm. Only 2 of 126 values are between 2 and 2.5 mm. Figure 5(b) shows the distribution of the differences in the 90%–50% penumbral width between the simulated and the measured data. All ΔP90–50 penumbral widths were smaller than 1.2 mm, and the mean value is about 0.4 mm. Figure 5(c) shows the data of the 80%–20% differences (absolute values). Only 1 of ΔP80–20 126 values is larger than 1.5 mm. The mean value of the distribution is about 0.5 mm. Figure 5(d) shows the absolute values of the field-size difference distribution in millimeters. The mean difference in field size between simulations and measurements was about 0.4 mm. Only 2 of 126 values were larger than 1 mm.

Figure 5.

Figure 5

Frequency distribution, f, of the absolute differences of penumbras between measured and simulated lateral profiles. The differences in the 90%–10% penumbra (ΔP90–10) are shown in panel (a), the values for the 90%–50% penumbra (ΔP90–50) are shown in panel (b), and the absolute differences in the 80%–20% penumbra are shown in panel (c). Panel (d) depicts the frequency distribution, f, of the absolute differences in field size (ΔFS).

Proton scattering results in the heterogeneous phantom

Table 4 summarizes the results of the comparison of simulations and measurements in the heterogeneous phantom containing bone- and lung-equivalent plastic devices (see also figures 6 and 7). The maximum dose difference of about 2% of the dose at the center of the SOBP was found in the PDD with the largest range, all other dose differences were smaller than 2%. The differences in the 80%–20% penumbras as well as the differences in ranges, were found to be smaller than or equal to 1.5 mm.

Table 4.

Comparison of simulated and measured PDDs and lateral profiles for the inhomogeneous geometry. Ep is the proton energy in MeV at nozzle entrance. SOBP width m of the SOBP was 10 cm in all cases;, and z is the depth of the profile relative to the upstream surface of the water phantom (isocenter) in millimeters. Δr is the absolute difference in range at the distal 90% dose location. The absolute differences in penumbra widths are denoted as ΔP80–20 for the 80%–20% penumbras. The maximum dose difference, ΔDmax, in the high-dose region of the profiles is given as a percentage of the dose normalized to the center of the profile. In the case of PDDs, the maximum dose difference was given as a percentage of dose normalized to the values at the center of the SOBP.

Type Ep
(MeV)
Δr
(mm)
z
(mm)
ΔP80–20
(mm)
ΔDmax
(%)
PDD 225 0.67 2.0
PDD 200 1.50 1.0
PDD 180 0.94 1.0
PDD 180* 1.28 1.3
LatProf 225 208 1.36 1.5
LatProf 200 162 0.43 1.5
LatProf 180 133 0.25 1.5
LatProf 180* 108 0.15 1.6

The Ep values with asterisks were measured and simulated with the full set of range shifter plates in the beam to deliver a beam with minimum range (for 180 MeV) in the phantom.

Figure 6.

Figure 6

PDDs (panels (a) and (b)) and lateral profiles (panels (c) and (d)) of proton dose downstream of the inhomogeneity set-up. Initial proton beam energy was 250 MeV (panels (a) and (c)) and 200 MeV (panels (b) and (d)). The depths, z, of the lateral profiles in the phantom were 20.8 cm (c) and 16.2 cm (d).

Figure 7.

Figure 7

PDDs and lateral profiles of proton dose downstream of the inhomogeneity set-up. The initial proton beam energy was 180 MeV. Panels, (a) and (c), show the data obtained with range shifters in the beam line. The depths, z, of the lateral profiles in the phantom were 10.8 cm (c) and 13.3 cm (d).

Discussion

In this study, we confirmed the dosimetric accuracy of the Monte Carlo model used at our PTCH by comparing its simulations of PDDs and lateral-dose profiles with measurements from a passive scattering proton treatment unit. The comparison included all range modulators, all scattering devices and two phantoms. The overwhelmingly good agreement between measured and simulated data suggests that the model is sufficiently accurate for use in clinical applications, such as treatment planning calculations.

This study offers several benefits. First, it is among the most comprehensive efforts ever made to validate the use of the Monte Carlo method for proton-therapy dose calculations. In addition, it examined a contemporary, commercially available treatment system that is of considerable clinical relevance. As well, this study was the logical extension of earlier works in this area, which have validated the MCNPX-based simulations for specific proton energies only, such as the study of the 250 and 180 MeV (medium-size) snouts ((Polf et al 2007); the study of an ocular treatment nozzle for very small fields and proton energies, i.e., below 100 MeV (Newhauser et al 2005a), the study of absorbed dose per monitor unit in an ocular treatment nozzle (Koch et al 2008), and the study of the dosimetric impact of tantalum markers in ocular treatments (Newhauser et al 2007c). The scope of our results, however, is much more comprehensive due the inclusion of all possible energies for the medium- and large-size double scattering snouts.

Another benefit of this study is that it validated dose predictions in a simple water phantom and in a heterogeneous phantom. In addition, our MCNPX model was robust, requiring only a detailed model of the beam-line geometry and selection of appropriate physics model parameters; no empirical adjustments to the model or corrections to the data were necessary.

One limitation of this study is the approximate treatment of the proton phase space as each proton history began. In particular, we approximated the starting proton beam as having zero emittance, whereas the manufacturer’s analytical calculations of the beam optics indicated the emittance was small but not zero. This does not appear to be a serious limitation, because the radiation-field properties in the phantoms were predominated by scattering in the nozzle components and in the phantom rather than by the emittance of the initial beam. In magnetically scanned nozzles, there is much less material in the beam path; therefore, the initial emittance of the beam may be more important in that setting. Another limitation is that we did not look as small field sizes. The reason was that experimental data were not available for such an analysis; however, this work is now in progress

The validation of the Monte Carlo system facilitates further development of advanced methods, algorithms and technologies. It confirms that the physics models are of sufficient accuracy for calculating relative dose distributions. Additional validation is still needed for small field sizes and for absolute dosimetry in terms of dose per monitor unit. However, future validation efforts will probably need to focus more on computer programming errors and less on the suitability of the physics models contained with the MCNPX code.

It is noteworthy that many of the simulation results were not optimized, i.e., the parameters of the model were not further refined once the results were within the acceptance criteria. This, in turn, means that the results presented in this study represent a scenario that is not necessarily the best case. Although all beams for the medium and large snouts can be simulated within tolerance limits, there is still the potential to improve simulation results. The results obtained by Polf et al (2007) indicate that substantial changes in the proximal region of a PDD can be achieved by changing the spatial size parameters of the proton source. The proximal region of the PDDs showed the largest discrepancies between simulated and measured data in this study (see figure 2). The discrepancies shown here may be caused by a shortcoming of accurately modeling the source. Possible other causes include small errors in the physics models used in the particle transport, small errors in the nuclear reaction cross sections, or the suppression of transport of secondary particles other than protons.

Also the efficiency of the Monte Carlo model has yet to be optimized, and there are many possible improvements to be implemented, such as additional variance reduction methods and an optimized choice of particle transport parameters, such as the energy cutoff value at which the proton transport will be terminated. The default value of 1 MeV was used in this study, but the range of a proton with the energy of 1 MeV in water is only about 27 µm, and a 1 mm range corresponds to a proton energy of about 9 MeV. Carefully chosen transport parameters can significantly improve the computation speed of the Monte Carlo system

Future studies underway at our institution will validate the Monte Carlo model to simulate the small double scattering snout of the PTCH, which provides field sizes up to 10 cm×10 cm, the actively scanned proton beam line and the ocular beam line.

Conclusion

The MCNPX-based Monte Carlo model of the nozzle for a passively scattered proton beam at the PTCH used to simulate dose distributions was found to be accurate after extensive comparison with measured dose distributions in a simple homogeneous water phantom and in a heterogeneous phantom. The results of this study will allow us to use this model in our study of dose distribution in more complex geometries, inhomogeneous media and patients. In 2 of 191 data sets, the maximum dose differences between measured and simulated dose profiles were larger than the tolerance criterion of maximum 3% dose difference and 3 mm distance to agreement; however, it was determined that these cases were lateral profiles in the distal falloff region, where the measured data showed large asymmetries probably due to small fluctuations in the beam steering. These two cases were plausibly explained and hence considered acceptable. Because the Monte Carlo system performed well over a wide range of proton energies, SOBP width and even in a heterogeneous phantom, containing heterogeneities of bone- and lung-equivalent material, it can be concluded that the physics implemented in MCNPX is adequate, and hence the code provides an excellent tool for applications in the radiotherapy environment, in particular, in proton therapy.

Furthermore, the AAPM Report no 105 addresses issues concerning clinical implementation of Monte Carlo based treatment planning systems for photon and electron radiation treatments. Validation of the Monte Carlo model is considered an integral part of the commissioning process of a treatment planning system. For proton therapy, no such document has been published yet. This study will therefore be of great interest for the charged particle treatment planning community.

Acknowledgments

The authors wish to express their gratitude to the Monte Carlo research team of the Department of Radiation Physics at The University of Texas M D Anderson Cancer Center for developing the beam line model and for supporting these validation efforts. Furthermore, we would like to thank the clinical physics team at the PTCH for providing the experimental data collected during the commissioning of the double scattering nozzles.

References

  1. Bues M, Newhauser WD, Titt U, Smith AR. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study. Radiat. Prot. Dosim. 2005;115:164–169. doi: 10.1093/rpd/nci259. [DOI] [PubMed] [Google Scholar]
  2. de Crevoisier R, et al. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:1529–1536. doi: 10.1016/j.ijrobp.2007.01.069. [DOI] [PubMed] [Google Scholar]
  3. Fontenot J, Taddei P, Zheng Y, Mirkovic D, Jordan T, Newhauser WD. Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy of the prostate. Phys. Med. Biol. 2008;53:1677–1688. doi: 10.1088/0031-9155/53/6/012. [DOI] [PubMed] [Google Scholar]
  4. Fontenot JD, Newhauser WD, Bloch C, White RA, Titt U, Starkschall G. Determination of output factors for small proton therapy fields. Med. Phys. 2007;34:489–498. doi: 10.1118/1.2428406. [DOI] [PubMed] [Google Scholar]
  5. Fontenot JD, Newhauser WD, Titt U. Design tools for proton therapy nozzles based on the double-scattering foil technique. Radiat. Prot. Dosim. 2005;116:211–215. doi: 10.1093/rpd/nci229. [DOI] [PubMed] [Google Scholar]
  6. Koch N, Newhauser W. Virtual commissioning of a treatment planning system for proton therapy of ocular cancers. Radiat. Prot. Dosim. 2005;115:159–163. doi: 10.1093/rpd/nci224. [DOI] [PubMed] [Google Scholar]
  7. Koch N, Newhauser WD, Titt U, Gombos D, Coombes K, Starkschall G. Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy. Phys. Med. Biol. 2008;53:1581–1594. doi: 10.1088/0031-9155/53/6/005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Koehler AM, Schneider RJ, Sisterson JM. Flattening of proton dose distributions for large-field radiotherapy. Med. Phys. 1977;4:297–301. doi: 10.1118/1.594317. [DOI] [PubMed] [Google Scholar]
  9. Melancon AD, et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother. Oncol. 2007;85:251–259. doi: 10.1016/j.radonc.2007.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mourtada F, Koch N, Newhauser W. 106Ru/106Rh plaque and proton radiotherapy for ocular melanoma: a comparative dosimetric study. Radiat. Prot. Dosim. 2005;116:454–460. doi: 10.1093/rpd/nci266. [DOI] [PubMed] [Google Scholar]
  11. Newhauser W, Fontenot J, Koch N, Dong L, Lee A, Zheng Y, Waters L, Mohan R. Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys. Med. Biol. 2007a;52:2937–2952. doi: 10.1088/0031-9155/52/11/001. [DOI] [PubMed] [Google Scholar]
  12. Newhauser W, Fontenot J, Zheng Y, Polf J, Titt U, Koch N, Zhang X, Mohan R. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys. Med. Biol. 2007b;52:4569–4584. doi: 10.1088/0031-9155/52/15/014. [DOI] [PubMed] [Google Scholar]
  13. Newhauser W, Koch N, Hummel S, Ziegler M, Titt U. Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams. Phys. Med. Biol. 2005a;50:5229–5249. doi: 10.1088/0031-9155/50/22/002. [DOI] [PubMed] [Google Scholar]
  14. Newhauser WD, Burns J, Smith AR. Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59. Med. Phys. 2002a;29:1953–1961. doi: 10.1118/1.1487425. [DOI] [PubMed] [Google Scholar]
  15. Newhauser WD, Ding X, Giragosian D, Nill S, Titt U. Neutron radiation area monitoring system for proton therapy facilities. Radiat. Prot. Dosim. 2005b;115:149–153. doi: 10.1093/rpd/nci127. [DOI] [PubMed] [Google Scholar]
  16. Newhauser WD, Koch NC, Fontenot JD, Rosenthal SJ, D SG, Fitzek MM, Mohan R. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy. Phys. Med. Biol. 2007c;52:3979–3990. doi: 10.1088/0031-9155/52/13/021. [DOI] [PubMed] [Google Scholar]
  17. Newhauser WD, Myers KD, Rosenthal SJ, Smith AR. Proton beam dosimetry for radiosurgery: implementation of the ICRU Report 59 at the Harvard Cyclotron Laboratory. Phys. Med. Biol. 2002b;47:1369–1389. doi: 10.1088/0031-9155/47/8/310. [DOI] [PubMed] [Google Scholar]
  18. Paganetti H, Jiang H, Lee SY, Kooy HM. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. Med. Phys. 2004;31:2107–2118. doi: 10.1118/1.1762792. [DOI] [PubMed] [Google Scholar]
  19. Polf JC, Harvey MC, Titt U, Newhauser WD, Smith AR. Initial beam size study for passive scatter proton therapy: I. Monte Carlo verification. Med. Phys. 2007;34:4213–4218. doi: 10.1118/1.2789497. [DOI] [PubMed] [Google Scholar]
  20. Polf JC, Newhauser WD. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams. Phys. Med. Biol. 2005;50:3859–3873. doi: 10.1088/0031-9155/50/16/014. [DOI] [PubMed] [Google Scholar]
  21. Polf JC, Newhauser WD, Titt U. Patient neutron dose equivalent exposures outside of the proton therapy treatment field. Radiat. Prot. Dosim. 2005;115:154–158. doi: 10.1093/rpd/nci264. [DOI] [PubMed] [Google Scholar]
  22. Smith AR, Newhauser WD, Latinkic M, Hay A, McMaken B, Styles J, Cox J. The University of Texas M D Anderson Cancer Center proton therapy facility; Proc. 17th Int. Conf. Application of Accelerators in Research and Industry; 2003. pp. 1073–1076. [Google Scholar]
  23. Titt U, Newhauser WD. Neutron shielding calculations in a proton therapy facility based on Monte Carlo simulations and analytical models: criterion for selecting the method of choice. Radiat. Prot. Dosim. 2005;115:144–148. doi: 10.1093/rpd/nci252. [DOI] [PubMed] [Google Scholar]
  24. Titt U, Zheng Y, Vassiliev ON, Newhauser WD. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method. Phys. Med. Biol. 2008;53:487–504. doi: 10.1088/0031-9155/53/2/014. [DOI] [PubMed] [Google Scholar]
  25. Vavilov PV. Ionization losses of high-energy heavy particles. Sov. Phys.—JETP. 1957;5:749. [Google Scholar]
  26. Waters LS, Hendricks J, McKinney G. MCNPX version 2.5.0. Los Alamos: Los Alamos National Laboratory; 2005. [Google Scholar]
  27. Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:620–629. doi: 10.1016/j.ijrobp.2006.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zheng Y, Newhauser W, Fontenot J, Taddei P, Mohan R. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy. Phys. Med. Biol. 2007a;52:4481–4496. doi: 10.1088/0031-9155/52/15/008. [DOI] [PubMed] [Google Scholar]
  29. Zheng Y, Newhauser WD, Fontenot J, Koch N, Mohan R. Monte Carlo simulations of stray neutron radiation exposures in proton therapy. J. Nucl. Mater. 2007b;361:289–297. [Google Scholar]

RESOURCES